Kebede H Begna

65PUBLICATIONS
181CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 23, 2026
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System and Systemic Classic Hodgkin Lymphoma in the Same Patient.

|Apr 06, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients.

Saubia Fathima, Lior Rokach, Nour Ghosoun

|Sep 03, 2025
Triple A Plus (AAA +) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients.

Ayalew Tefferi, Giuseppe G Loscocco, Lior Rokach

|Jun 24, 2025
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes.

Clifford M Csizmar, Anuya Natu, Mark Gurney

|May 22, 2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

Pageof 11

Frequent Collaborators

46 joint publications

Naseema Gangat

45 joint publications

Ayalew Tefferi

42 joint publications

Mrinal S Patnaik

33 joint publications

Aref Al-Kali